DTaP-IPV-HepB-PRP-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DTaP-IPV-HepB-PRP-T, covering 2016-01-05 to 2016-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination [Phase 3]